Get the Stockscreener App
0.7678
10.32%
0.0718
After Hours:
.70
-0.0678
-8.83%
Zhengye Biotechnology Holding Ltd stock is traded at $0.7678, with a volume of 59,094.
It is up +10.32% in the last 24 hours and down -7.55% over the past month.
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.
See More
Previous Close:
$0.696
Open:
$0.696149
24h Volume:
59,094
Relative Volume:
0.78
Market Cap:
$36.39M
Revenue:
$16.18M
Net Income/Loss:
$-11.58M
P/E Ratio:
-3.7344
EPS:
-0.2056
Net Cash Flow:
$98,700
1W Performance:
+13.40%
1M Performance:
-7.55%
6M Performance:
-32.65%
1Y Performance:
-86.14%
1-Day Range:
$0.6801
$0.769
1-Week Range:
$0.6155
$0.769
52-Week Range:
$0.6155
$13.08
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Company Profile
Compare ZYBT vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZYBT
Zhengye Biotechnology Holding Ltd
|
0.7678 | 32.98M | 16.18M | -11.58M | 98,700 | -0.2056 |
TAK
Takeda Pharmaceutical Co Adr
|
16.96 | 53.37B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.84 | 42.80B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.65 | 41.09B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.29 | 31.62B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
563.70 | 23.23B | 3.17B | 1.29B | 1.01B | 27.09 |
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Latest News
AI Models Turn Less Negative on ZYBT but Keep Risk Warnings in Place - TipRanks
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Zhengye Biotechnology Holding Ltd (ZYBT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Zhengye Biotechnology Holding Ltd (ZYBT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Zhengye Biotechnology Holding Ltd (ZYBT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Zhengye Biotechnology Holding Ltd (ZYBT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Zhengye Biotechnology Holding Ltd (ZYBT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Zhengye Biotechnology Holding Ltd (ZYBT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Zhengye Biotechnology Holding Ltd (ZYBT) Institutional Confidence - TradingKey
Zhengye Biotechnology Holding Ltd (ZYBT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Zhengye Biotechnology Holding Ltd - TradingKey
Zhengye Biotechnology receives Nasdaq bid price deficiency notice By Investing.com - Investing.com Australia
Zhengye Biotechnology receives Nasdaq bid price deficiency notice - Investing.com UK
Zhengye Biotechnology Receives Nasdaq Letter for Minimum Bid Price Deficiency - marketscreener.com
Zhengye Biotechnology Faces Nasdaq Minimum Bid Price Deficiency After May 29 Notice - TipRanks
Zhengye Biotech has 6 months to lift stock back above $1 - Stock Titan
Zhengye Biotech's Nasdaq Lifeline: A 180-Day Race Against Financial Reality - BriefGlance
ZYBTZhengye Biotechnology Holding Ltd Stock Price and Quote - Finviz
ZYBT Stock Price, Quote & Chart | ZHENGYE BIOTECHNOLOGY-A (NASDAQ:ZYBT) - ChartMill
TradingKey - TradingKey
Zhengye (ZYBT) quarterly report delayed as CEO highlights strategic priorities; investors await key financial data. - The Legal Advocate
Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results - Tirto.id
China hog slump hits Zhengye as vaccine maker posts annual loss - Stock Titan
How risky is Zhengye (ZYBT) stock investment? (Institutional Selling) 2026-04-27Earnings Beat Stocks - newser.com
ZYBT Price Today: Zhengye Biotechnology Holding Limited Stock Price, Quote & Chart | MEXC - MEXC Exchange
Why Zhengye (ZYBT) Stock Could Rise (+3.79%) 2026-04-20Retail Picks - newser.com
Aiden Han Net Worth (2026) - GuruFocus
Wei Lian Net Worth (2026) - GuruFocus
Zhongyao Liu Net Worth (2026) - GuruFocus
Wenhua Sun Net Worth (2026) - GuruFocus
Zhengye Biotechnology posts $0.24 EPS $186M revenue no estimatesShort-Term Outlook - The Legal Advocate
Trading Recap: Will Zhengye Biotechnology Holding Limited stock hit new highs in YEARQuarterly Trade Summary & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Zhengye Biotechnology implements dual-class share structure - Investing.com
Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure - Weekly Voice
Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure Effective April 7, 2026 - Quiver Quantitative
Zhengye's new share classes give some holders 20 votes each - Stock Titan
ZYBT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
ZYBT Technical Analysis & Stock Price Forecast - Intellectia AI
Death Cross: How does Zhengye Biotechnology Holding Limited correlate with NasdaqInflation Watch & Stock Timing and Entry Methods - baoquankhu1.vn
Zhengye Biotechnology Shareholders Approve Governance and Share Structure Changes at March 24 AGM - TipRanks
Why Faraday Future Intelligent Electric Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket - Benzinga
$Zhengye Biotechnology (ZYBT.US)$ still hodl some for moon - Moomoo
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Kyverna Therapeutics (NASDAQ:KYTX) and Zhengye Biotechnology (NASDAQ:ZYBT) Critical Contrast - Defense World
ZYBT Should I Buy - Intellectia AI
Zhengye Biotechnology Director Resigns, Nasdaq Independence Deficiency to Be Addressed at March AGM - TipRanks
Zhengye Biotechnology Holding Limited Announces Resignation of Wenbin Wang as Independent Director, Member of Committees, and Chairperson of the Compensation Committee, Effective February 18, 2026 - marketscreener.com
Will Zhengye Biotechnology Holding Limited benefit from geopolitical trendsChart Signals & Trade Opportunity Analysis Reports - mfd.ru
Zhengye Biotech chairman outlines 2025 achievements, 2026 strategy By Investing.com - Investing.com South Africa
Zhengye Biotechnology Holding Limited Issues 2026 Chairman’s Letter to Shareholders - GlobeNewswire
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.17%
1.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):